CAMKII as a therapeutic target for growth factor–induced retinal and choroidal neovascularizationSadaf Ashraf(University of Nottingham), Tim M. CurtisJCI InsightFebruary 5, 201910.1172/jci.insight.122442Cited by 15SaveCiteExport RISWatch citationsRelated PapersThe polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis|Scientific Reports|2019|48Loss of TRPV2-mediated blood flow autoregulation recapitulates diabetic retinopathy in rats|JCI Insight|2022|21